Sidra Medicine Contributes to International AI Study Advancing Neonatal Care

Sidra Medicine, a member of Qatar Foundation, has contributed to a major international study demonstrating how artificial intelligence (AI) models originally developed for adult patients can be adapted to support neonatal care.

10 November, 2026

Msheireb Museums and Sidra Medicine Host Fifth Science Café Session on Fertility and Reproductive Health

As part of their joint efforts to raise community awareness of health and scientific issues, Msheireb Museums, in partnership with Sidra Medicine, hosted the fifth session of the Science Café series under the theme “Health and Future Generations: Your Guide to Fertility”

9 November, 2026

Sidra Medicine and Msheireb Museums Introduce Women’s Health Conversation Series

Sidra Medicine, in collaboration with Msheireb Museums, has launched a new Women’s Health Conversation Series, “From the Neighborhood to the Clinic”.

7 November, 2026

Qatar Precision Health Institute Joins PMFG Summit 2026 as Strategic Partner and Co-Organizer

Sidra Medicine and Qatar Precision Health Institute (QPHI), have jointly announced QPHI as a strategic partner and co-organizer of the Precision Medicine and the Future of Genomics (PMFG) Summit 2026, for the second consecutive year.

4 November, 2026

Sidra Medicine Establishes the Middle East’s First Atlas of DNA Variants Shaping Genome Regulation

Researchers at Sidra Medicine, a member of Qatar Foundation, have created the Middle East’s first population-scale atlas showing how genetic variation regulates gene activity in blood and tracing its effects to clinical traits.

28 October, 2026

Sidra Medicine and Qatar Museums Investigate Evidence of Spina Bifida in Ancient Qatar

Sidra Medicine and Qatar Museums are leading a multidisciplinary research project that brings together archaeology, advanced medical imaging, and molecular research to investigate the lives and health of Qatar's prehistoric populations.

28 October, 2026

RSV Poses Greater Risk of Hospitalization for Children Than Flu or COVID-19, Qatar Study Finds

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) and Sidra Medicine, in collaboration with the Ministry of Public Health and Hamad Medical Corporation, have found that respiratory syncytial virus (RSV) was associated with substantially more severe illness than influenza or COVID-19 among children in Qatar.

18 October, 2026

Sidra Medicine Concludes MENA Microbiome 2026 urging stronger collaboration on translating clinical discoveries into clinical applications

Last day featured discussions on gut-organ interactions, rapid metagenomics, and antimicrobial resistance, alongside a Sidra Medicine-led research collaboration aimed at advancing early sepsis prediction and patient care in Qatar

17 October, 2026

Sidra Medicine Advances Microbiome Research and Future Therapeutic Opportunities at MENA Microbiome 2026

Day 1 highlights Qatar's QMicrobe initiative, advances in precision nutrition during pregnancy, and emerging microbiome-based therapies for women and children

Sidra Medicine Contributes to International AI Study Advancing Neonatal Care

Msheireb Museums and Sidra Medicine Host Fifth Science Café Session on Fertility and Reproductive Health

Sidra Medicine and Msheireb Museums Introduce Women’s Health Conversation Series

Qatar Precision Health Institute Joins PMFG Summit 2026 as Strategic Partner and Co-Organizer

Sidra Medicine Establishes the Middle East’s First Atlas of DNA Variants Shaping Genome Regulation

Sidra Medicine and Qatar Museums Investigate Evidence of Spina Bifida in Ancient Qatar

RSV Poses Greater Risk of Hospitalization for Children Than Flu or COVID-19, Qatar Study Finds

Sidra Medicine Concludes MENA Microbiome 2026 urging stronger collaboration on translating clinical discoveries into clinical applications

Sidra Medicine Advances Microbiome Research and Future Therapeutic Opportunities at MENA Microbiome 2026

Our Insurance Partners